Introduces digital mammography system which significantly minimizes the ‘miss’ rate in breast cancer detection; Requests hospitals across the world to put-up awareness posters
- India accounts for nearly 6% of deaths due to breast cancer globally
- One out of every 22 women in India is diagnosed with breast cancer
- Breast cancer is rapidly pushing cervical cancer to the second spot
“Ask for Breast Cancer Screening TODAY for Your FUTURE. Breast cancer is the number one cancer that affects the women. Routine screening makes a difference. FUJIFILM supports the campaign,” reads FUJIFILM poster which the Company requests the hospitals across the world to put up on Pink Ribbon Day (the fourth Monday of October every year) – a day that marks breast cancer awareness and fund raising activities across the world.
FUJIFILM India Pvt. Ltd., the wholly owned subsidiary of FUJIFILM Corporation, one of the largest medical systems company in the world, has upped the ante against breast cancer with the launch of AMULET – its digital mammography system in India recently. This launch not only enhances its medical systems line-up in the country but also reaffirms FUJIFILM’s resolve against the global menace of breast cancer.
According to Mr. Kenichi Tanaka, Managing Director, FUJIFILM India, “We pioneered digital mammography more than 20 years ago, and since then, we have been the market leaders in the domain. We are proud of this achievement and shall strive further to fight the global menace of breast cancer.”
“FUJIFILM will continue to contribute to maintaining and promoting human health through developing Digital mammography solutions and other leading-edge products, and supporting the Pink Ribbon campaign, which appeals the importance of early detection, early diagnosis and early treatment for breast cancer,” said Mr. Suhas Pokale, Country General Manager Fujifilm India Pvt. Ltd.
Despite the recent technological advances, there is still a ‘miss’ rate, though significantly lower, as far as detection of breast cancer is concerned. The new digital mammography system launched by FUJIFILM provides world's smallest pixel size of 50µm and produces both high resolution and low noise images which contribute to more accurate diagnosis of breast cancer and therefore reducing the miss rate dramatically. AMULET system can show micro-calcifications and tumours in greater detail, both significant indicators for early diagnosis of breast cancer. AMULET also reduces the interval between two x-ray exposures by approximately 15 seconds. This allows many images to be captured more rapidly thus improving workflow and reducing stress for those waiting for examinations. The ergonomic design of the unit was developed following the thorough evaluation by experienced female radiologic technologists. The discomfort during examination has been significantly reduced by the design of armrests which allow a comfortable position to be maintained and the use of various pads around the breast support to further reduce discomfort.
About FUJIFILM
FUJIFILM Corporation (NASDAQ:FUJI) brings continuous innovation and leading-edge products to a broad spectrum of industries, including electronic imaging, photofinishing equipment, medical systems, life sciences, graphic arts, flat panel display materials, and office products, based on a vast portfolio of digital, optical, fine chemical and thin film coating technologies. The company was among the top 15 companies around the world granted U.S. patents in 2008, employs more than 70,000 people worldwide and in the year ended March 31, 2008, had global revenues of $24.7 billion. Fujifilm is committed to environmental stewardship and good corporate citizenship. For more information, please visit www.fujifilm.com / www.fujifilm.in
